Metabolism of minor isoforms of prion proteins Cytosolic prion protein and transmembrane prion protein

被引:4
|
作者
Song, Zhiqi [1 ]
Zhao, Deming [1 ]
Yang, Lifeng [1 ]
机构
[1] China Agr Univ, State Key Lab Agrobiotechnol, Natl Anim Transmissible Spongiform Encephalopathy, Coll Vet Med, Beijing 100193, Peoples R China
基金
中国国家自然科学基金;
关键词
neural regeneration; neurodegeneration; prion protein; cytosolic form of prion protein; transmembrane form of priori protein; metabolism; protein degeneration; ubiquitination; molecular chaperone; molecular mechanism; neuroregeneration; ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; PRPSC-LIKE CONFORMATION; NEURODEGENERATIVE DISEASES; SPONGIFORM ENCEPHALOPATHY; PROTEASOME DEGRADATION; TRANSLOCATION CHANNEL; SECRETORY PATHWAY; MAMMALIAN PRIONS; QUALITY-CONTROL;
D O I
10.3969/j.issn.1673-5374.2013.30.009
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Transmissible spongiform encephalopathy or prion disease is triggered by the conversion from cellular prion protein to pathogenic prion protein. Growing evidence has concentrated on prion protein configuration changes and their correlation with prion disease transmissibility and pathogenicity. In vivo and in vitro studies have shown that several cytosolic forms of priori protein with specific topological structure can destroy intracellular stability and contribute to priori protein pathogenicity. In this study, the latest molecular chaperone system associated with endoplasmic reticulum-associated protein degradation, the endoplasmic reticulum resident protein quality-control system and the ubiquitination proteasome system, is outlined. The molecular chaperone system directly correlates with the prion protein degradation pathway. Understanding the molecular mechanisms will help provide a fascinating avenue for further investigations on prion disease treatment and prion protein-induced neurodegenerative diseases.
引用
收藏
页码:2868 / 2878
页数:11
相关论文
共 50 条
  • [21] The fate of the prion protein in the prion/plasminogen complex
    Kornblatt, JA
    Marchal, S
    Rezaei, H
    Kornblatt, MJ
    Balny, C
    Lange, R
    Debey, MP
    Hoa, GHB
    Marden, MC
    Grosclaude, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 305 (03) : 518 - 522
  • [22] Prion Protein Functions and Dysfunction in Prion Diseases
    Sakudo, Akikazu
    Ikuta, Kazuyoshi
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (03) : 380 - 389
  • [23] Protective role of cytosolic prion protein against virus infection in prion-infected cells
    Hara, Hideyuki
    Chida, Junji
    Batchuluun, Batzaya
    Takahashi, Etsuhisa
    Kido, Hiroshi
    Sakaguchi, Suehiro
    JOURNAL OF VIROLOGY, 2024, 98 (09)
  • [24] Role of microglia and host prion protein in neurotoxicity of a prion protein fragment
    Brown, DR
    Schmidt, B
    Kretzschmar, HA
    NATURE, 1996, 380 (6572) : 345 - 347
  • [25] Prion protein expression in muscle cells and toxicity of a prion protein fragment
    Brown, DR
    Schmidt, B
    Groschup, MH
    Kretzschmar, HA
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1998, 75 (01) : 29 - 37
  • [26] PURIFICATION AND PROPERTIES OF THE CELLULAR AND SCRAPIE PRION PROTEIN ISOFORMS
    TURK, E
    TEPLOW, DB
    HOOD, LE
    PRUSINER, SB
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, 35 (04) : 372 - 372
  • [27] PRION PROTEIN ISOFORMS, A CONVERGENCE OF BIOLOGICAL AND STRUCTURAL INVESTIGATIONS
    BALDWIN, MA
    COHEN, FE
    PRUSINER, SB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (33) : 19197 - 19200
  • [28] Factors affecting interactions between prion protein isoforms
    Caughey, B
    Baron, GS
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 : 565 - 569
  • [29] In vitro conversion of normal prion protein into pathologic isoforms
    Bossers, A
    Rigter, A
    de Vries, R
    Smits, MA
    CLINICS IN LABORATORY MEDICINE, 2003, 23 (01) : 227 - +
  • [30] Interactions between prion protein isoforms: the kiss of death?
    Caughey, B
    TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (04) : 235 - 242